Urinary retention. Neuromuscular dysfunction of bladder, unspecified
Conditions
Interventions
Intervention 1: 3 dose of tamsulosine capsule 0.4mg orally (2 dose during 14 and 2 hours before surgery and one dose 10 hours after surgery). Intervention 2: 3 dose of placebo orally (2 dose during 14
Treatment - Drugs
Placebo
3 dose of tamsulosine capsule 0.4mg orally (2 dose during 14 and 2 hours before surgery and one dose 10 hours after surgery)
3 dose of placebo orally (2 dose during 14 and 2 hours before surgery and one dose 10 hours after surgery)
Sponsors
Guilan Urology Research Center
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: men with 18-50 that underwent spinal anesthesia with 2cc lidocaine for scrotal surgery, varicocelectomy or herniorrahphy and duration of their surgery are less than 90 min Exclusion criteria: urinary symptom before surgery, history of urinary retention, history of neurologic disease, pelvic surgery history, history of benzodiazepine consumption, beta agonist and alpha agonist before surgery, IV fluid intake during surgery more than 1500cc, use of anesthetic drugs except for lidocaeine for spinal anesthesia and duration of surgery more than 90 min
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary retention. Timepoint: during 24 hours after surgery. Method of measurement: Medical history, physical examination, urine volume after catheterization. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hamidreza Baghani Aval
Urology Research Center
Outcome results
None listed